HIF1A and ovarian carcinoma: In vitro and in vivo, silencing TRPM7 increased the activation of AMPK and stimulated the ubiquitination and degradation of HIF-1α, thus attenuating the HIF-1α-enhanced glycolysis, and inhibiting the proliferation of ovarian cancer cells (195).